Rocky Cares is a nonprofit organization dedicated to accelerating the development of a cure for Ewing sarcoma by funding research and fostering collaborations among scientists, clinicians, and partner institutions. The group supports clinical trial initiatives and provides resources to patients and families affected by the disease, aiming to translate scientific breakthroughs into effective treatments.
Funding
Funding not disclosed
Founders
Product
Problem
Ewing sarcoma is a rare and aggressive pediatric bone cancer with limited treatment options and low survival rates, leaving patients and families with few avenues for hope and support.
Solution
Rocky Cares mobilizes community resources to fund research aimed at discovering targeted therapies for Ewing sarcoma. By raising awareness and collecting donations, the organization provides financial support to scientific projects focused on developing curative treatments. It also honors the memory of Rocky Elardo through annual scholarships that recognize high‑school seniors exemplifying her spirit, thereby fostering community engagement and sustained advocacy for the cause. Partnerships with donors, medical institutions, and other nonprofits amplify the impact of its fundraising efforts, creating a collaborative network dedicated to accelerating a cure.
Target Audience
Primary supporters include families affected by Ewing sarcoma, individual donors, and community groups seeking to contribute to pediatric cancer research and scholarship programs.
Features
- Dedicated fundraising campaigns that channel contributions directly to Ewing sarcoma research initiatives
- Annual legacy scholarships for high‑school seniors who demonstrate academic excellence, athletic ability, and community kindness
- Community outreach programs that raise awareness about Ewing sarcoma and the need for targeted therapeutic development
- Collaboration with research institutions and partner organizations to align funding with high‑impact scientific projects
- Transparent reporting of donation allocation and research progress to donors and supporters